Two new pterosin dimers from Pteris mutifida Poir

Area of Science:

• Natural Product Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Pteris multifida is a plant known to contain various bioactive compounds.
• Pterosin dimers represent a class of natural products with potential biological activities.
• Understanding the chemical diversity and biological properties of plant-derived compounds is crucial for drug discovery.

Purpose of the Study:

• To isolate and characterize novel pterosin dimers from Pteris multifida.
• To elucidate the structures of the isolated compounds using spectroscopic methods.
• To evaluate the cytotoxic potential of the new compounds against a human leukemia cell line.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation employing Nuclear Magnetic Resonance (NMR) and Mass Spectrometry (MS) data.
• Cytotoxicity assays using the HL-60 cell line to determine IC50 values.

Main Results:

• Two new C14 pterosin dimers, bimutipterosins A (1) and B (2), were successfully isolated.
• The structures were confirmed through comprehensive analysis of NMR and MS data.
• Both compounds demonstrated cytotoxicity against HL-60 cells, with IC50 values of 12.8 μM for bimutipterosin A and 26.6 μM for bimutipterosin B.
• The isolated compounds are proposed to be [2+2] dimerization products of dehydropterosin Q.

Conclusions:

• This study reports the first isolation and structural characterization of a novel type of pterosin dimer.
• Bimuthipterosins A and B represent potential leads for the development of new anticancer agents targeting leukemia.
• The findings contribute to the understanding of the biogenesis of pterosin derivatives in Pteris multifida.